Provided by Tiger Trade Technology Pte. Ltd.

Rhythm Pharmaceuticals Inc.

102.20
+1.141.13%
Post-market: 102.200.00000.00%19:30 EDT
Volume:422.89K
Turnover:43.13M
Market Cap:7.04B
PE:-32.79
High:102.89
Open:99.88
Low:99.88
Close:101.06
52wk High:122.20
52wk Low:74.50
Shares:68.85M
Float Shares:65.39M
Volume Ratio:0.97
T/O Rate:0.65%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.1172
EPS(LYR):-3.1100
ROE:-117.04%
ROA:-30.96%
PB:68.33
PE(LYR):-32.86

Loading ...

Rhythm says setmelanotide cuts BMI 16.9% at 12 months in acquired hypothalamic obesity study

Reuters
·
May 12

Guggenheim Remains a Buy on Rhythm Pharmaceuticals (RYTM)

TIPRANKS
·
May 11

iBio names Elizabeth Stoner to board as Schimmelpennink steps down

Reuters
·
May 08

Rhythm Pharmaceuticals Is Maintained at Buy by Canaccord Genuity

Dow Jones
·
May 08

Rhythm Pharmaceuticals price target raised to $143 from $140 at Canaccord

TIPRANKS
·
May 08

Rhythm Pharmaceuticals Analysts Boost Their Forecasts Following Upbeat Q1 Results

Benzinga Earnings
·
May 07

Rhythm Pharma CEO joins Bank of America Global Healthcare Conference fireside chat

Reuters
·
May 06

Rhythm Pharmaceuticals (RYTM) Receives a Buy from Guggenheim

TIPRANKS
·
May 06

BUZZ-U.S. STOCKS ON THE MOVE-TransDigm, Rhythm Pharmaceuticals, Intel

Reuters
·
May 06

Analysts Offer Insights on Healthcare Companies: Rhythm Pharmaceuticals (RYTM) and Viridian Therapeutics (VRDN)

TIPRANKS
·
May 06

Stock Track | Rhythm Pharmaceuticals Soars 12.79% Intraday on Better-Than-Expected Q1 Results Driven by IMCIVREE Launch

Stock Track
·
May 05

Rhythm Pharmaceuticals Inc reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
May 05

Rhythm Pharmaceuticals Shares up 7.5% Premarket After Q1 Revenue Rises

THOMSON REUTERS
·
May 05

Rhythm Pharmaceuticals Q1 revenue rises 84%

Reuters
·
May 05

Rhythm Q1 FY26 net loss widens to $56.7 million; revenue rises to $60.1 million

Reuters
·
May 05

Stock Track | Rhythm Pharmaceuticals Soars 9.84% in Pre-market on Better-Than-Expected Q1 Results

Stock Track
·
May 05

Rhythm Pharmaceuticals Q1 EPS $(0.83) Beats $(0.84) Estimate, Sales $60.112M Beat $55.776M Estimate

Benzinga Earnings
·
May 05

BRIEF-Rhythm Pharmaceuticals Q1 Net Income USD -55.639 Million Vs. IBES Estimate USD -55.3 Million

Reuters
·
May 05

Rhythm Pharmaceuticals Reports First Quarter 2026 Financial Results and Business Update

THOMSON REUTERS
·
May 05

Rhythm Pharmaceuticals presents Phase 3 TRANSCEND trial data

TIPRANKS
·
May 04